Kinney Horn - Mar 10, 2022 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role: CHIEF BUSINESS OFFICER
Signature: /s/ John B. Moriarty, Jr., Attorney-in-Fact
Stock symbol: OLMA
Transactions as of: Mar 10, 2022
Transactions value $: -$14,110
Form type: 4
Date filed: 3/14/2022, 04:45 PM
Previous filing: Feb 14, 2022
Next filing: Feb 2, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OLMA	Common Stock	Options Exercise	$10.8K	+5.25K	+213.71%	$2.06^*	7.71K	Mar 10, 2022	Direct
transaction	OLMA	Common Stock	Sale	-$25K	-5.25K	-68.12%	$4.75	2.46K	Mar 10, 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OLMA	Stock Option (Right to Buy)	Options Exercise	$0	-5.25K	-3.57%	$0.00	142K	Mar 10, 2022	Common Stock	5.25K	$2.06	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the reporting person.
F2	The shares subject to the option vest in a series of 48 successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continuous service through each applicable vesting date.